Substantive final action
HB766
Senate Vote on HB 766 FINAL PASSAGE (#1341)
Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
Passed Senate May 26, 2026⭐ Substantive final action
Yea (37)
Absent (2)
Republicans (28)
100% yea among members casting a yea or nay vote (28–0).
Democrats (11)
100% yea among members casting a yea or nay vote (9–0).